International Journal of Cancer

Article	Citations
Cancer statistics for the year 2020: An overview	3059
Lipocalin 2 expression promotes tumor progression and therapy resistance by inhibiting ferroptosis in colorectal cancer	121
Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using GLOBOCAN 2020	119
The role of exosomes in liquid biopsy for cancer diagnosis and prognosis prediction	105
Caspase‐8: A key protein of cross‐talk signal way in “PANoptosis” in cancer	100
Thyroid cancer, recent advances in diagnosis and therapy	82
Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC‐ESCC2019): A multicenter, phase 2 study	76
Predicted long‐term impact of COVID‐19 pandemic‐related care delays on cancer mortality in Canada	73
Burden of pancreatic cancer along with attributable risk factors in Europe between 1990 and 2019, and projections until 2039	73
Cancer in Iran 2008 to 2025: Recent incidence trends and short‐term predictions of the future burden	71
Composite dietary antioxidant index and the risk of colorectal cancer: Findings from the Singapore Chinese Health Study	60
Dysbiosis of the endometrial microbiota and its association with inflammatory cytokines in endometrial cancer	60
Single‐cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer	59
Global patterns in testicular cancer incidence and mortality in 2020	57
Randomized clinical trial of pembrolizumab vs chemotherapy for previously untreated Chinese patients with PD‐L1‐positive locally advanced or metastatic non–small‐cell lung cancer: KEYNOTE‐042 China St	56
Trastuzumab in combination with 5‐fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2‐positive locally advanced es	56
GSDME and its role in cancer: From behind the scenes to the front of the stage	56
Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive‐stage small cell lung cancer: A multicentre, randomised, double‐blind, placebo‐controlled Phase II	55
Esophageal cancer in China: Practice and research in the new era	54
S100 calcium‐binding protein A9 from tumor‐associated macrophage enhances cancer stem cell‐like properties of hepatocellular carcinoma	53
Histone lysine demethylases and their functions in cancer	51
A systematic review and meta‐analysis of cytology and HPV‐related biomarkers for anal cancer screening among different risk groups	49
Wnt pathway modulators in cancer therapeutics: An update on completed and ongoing clinical trials	47
Circulating insulin‐like growth factor‐I, total and free testosterone concentrations and prostate cancer risk in 200 000 men in UK Biobank	47
The effects of TNF‐α/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer	46

Clinical impact of probiotics on the efficacy of anti‐PD‐1 monotherapy in patients with nonsmall cell lung cancer: A multicenter retrospective survival analysis study with inverse probabili	46
Exploring the interactions between Helicobacter pylori (Hp) infection and other risk factors of gastric cancer: A pooled analysis in the Stomach cancer Pooling (StoP) Project	46
Tumor‐associated macrophage‐targeted therapeutics in ovarian cancer	45
Prospective analyses of testosterone and sex hormone‐binding globulin with the risk of 19 types of cancer in men and postmenopausal women in UK Biobank	45
Endometrial cancer in Lynch syndrome	45
International trends in incidence of osteosarcoma (1988‐2012)	44
Meta‐analysis of agreement/concordance statistics in studies comparing self‐ vs clinician‐collected samples for HPV testing in cervical cancer screening	44
Feasibility of deep learning‐based fully automated classification of microsatellite instability in tissue slides of colorectal cancer	44
Long‐term exposure to air pollution and liver cancer incidence in six European cohorts	44
Associations of fecal microbial profiles with breast cancer and nonmalignant breast disease in the Ghana Breast Health Study	43
Epigenetic regulation of cancer stem cell formation and maintenance	43
The unveiled reality of human papillomavirus as risk factor for oral cavity squamous cell carcinoma	42
Diagnosis of digestive system tumours	42
Personalising lung cancer screening: An overview of risk‐stratification opportunities and challenges	42
Circulating liver function markers and colorectal cancer risk: A prospective cohort study in the UK Biobank	42
International Anal Neoplasia Society's consensus guidelines for anal cancer screening	42
Late effects, long‐term problems and unmet needs of cancer survivors	40
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476)	40
The development of “automated visual evaluation” for cervical cancer screening: The promise and challenges in adapting deep‐learning for clinical testing	39
Cancer risk and mortality after solid organ transplantation: A population‐based 30‐year cohort study in Finland	37
Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients	37
Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II	37
Cross‐sectional survey of the impact of the COVID‐19 pandemic on cancer screening programs in selected low‐ and middle‐income countries: Study from the IARC COVID‐19 impact study	36
Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017	36
A randomized trial of risk‐adapted screening for prostate cancer in young men—Results of the first screening round of the PROBASE trial	36
Causal relationships between inflammatory factors and multiple myeloma: A bidirectional Mendelian randomization study	35
CD25: A potential tumor therapeutic target	35
Global burden of HPV‐attributable squamous cell carcinoma of the anus in 2020, according to sex and HIV status: A worldwide analysis	35
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab	34
Alcohol consumption, DNA methylation and colorectal cancer risk: Results from pooled cohort studies and Mendelian randomization analysis	34
Cancer incidence and cancer death in relation to tobacco smoking in a population‐based Australian cohort study	34
Epidemiology, genetics and treatment of multiple myeloma and precursor diseases	34
Novel imaging techniques for intraoperative margin assessment in surgical oncology: A systematic review	33
Global and national trends in the age‐specific sex ratio of esophageal cancer and gastric cancer by subtype	33
Alterations in the oral and gut microbiome of colorectal cancer patients and association with host clinical factors	33
Exposures to pesticides and risk of cancer: Evaluation of recent epidemiological evidence in humans and paths forward	33
Oral and gastric microbiome in relation to gastric intestinal metaplasia	33
Dietary inflammatory potential, oxidative balance score, and risk of breast cancer: Findings from the Sister Study	33
Clinical validation of p16/Ki‐67 dual‐stained cytology triage of HPV‐positive women: Results from the IMPACT trial	32
Mendelian randomization analyses of 23 known and suspected risk factors and biomarkers for breast cancer overall and by molecular subtypes	32
Chronic restraint stress promotes the mobilization and recruitment of myeloid‐derived suppressor cells through β‐adrenergic‐activated CXCL5‐CXCR2‐Erk signaling cascades	32
Dietary intake and plasma phospholipid concentrations of saturated, monounsaturated and trans fatty acids and colorectal cancer risk in the European Prospective Investigation into Cancer and Nu	31
Hepatitis B virus infection and the risk of gastrointestinal cancers among Chinese population: A prospective cohort study	31
Detection of circulating tumor human papillomavirus DNA before diagnosis of HPV‐positive head and neck cancer	31
Postdiagnosis body fatness, weight change and breast cancer prognosis: Global Cancer Update Program (CUP global) systematic literature review and meta‐analysis	31
Camrelizumab plus oxaliplatin‐based chemotherapy as first‐line therapy for advanced biliary tract cancer: A multicenter, phase 2 trial	31
Do certified cancer centers provide more cost‐effective care? A health economic analysis of colon cancer care in Germany using administrative data	30
NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division	30
Withdrawn: circLgr4 drives colorectal tumorigenesis and invasion through Lgr4‐targeting peptide	29
Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV‐related oropharyngeal cancer and cancer of unknown primary	29

Acute aerobic exercise‐conditioned serum reduces colon cancer cell proliferation in vitro through interleukin‐6‐induced regulation of DNA damage	29
Tumor‐stroma ratio is associated with Miller‐Payne score and pathological response to neoadjuvant chemotherapy in HER2‐negative early breast cancer	28
DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicine	28
PhaseIIstudy of durvalumab monotherapy in patients with previously treated microsatellite instability‐high/mismatch repair‐deficient orPOLE‐mutated metastatic or unresecta	28
Progress, challenges and ways forward supporting cancer surveillance in Latin America	28
Circulating tumor DNA for prognosis assessment and postoperative management after curative‐intent resection of colorectal liver metastases	27
Annexin A2: The diversity of pathological effects in tumorigenesis and immune response	27
Overall survival benefit of osimertinib and clinical value of upfront cranial local therapy in untreated EGFR‐mutant nonsmall cell lung cancer with brain metastasis	27
The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?	27
Reviewing the impact of 11 national Be Clear on Cancer public awareness campaigns, England, 2012 to 2016: A synthesis of published evaluation results	27
Characteristics and outcome of pediatric renal cell carcinoma patients registered in the International Society of Pediatric Oncology (SIOP) 93‐01, 2001 and UK‐IMPORT database: A	27
HOXD13 suppresses prostate cancer metastasis and BMP4‐induced epithelial‐mesenchymal transition by inhibiting SMAD1	27
Alcohol metabolism genes and risks of site‐specific cancers in Chinese adults: An 11‐year prospective study	27
Global patterns of Hodgkin lymphoma incidence and mortality in 2020 and a prediction of the future burden in 2040	27
Neoadjuvant docetaxel plus carboplatin vs epirubicin plus cyclophosphamide followed by docetaxel in triple‐negative, early‐stage breast cancer (NeoCART): Results from	26
Risk‐stratified strategies in population screening for colorectal cancer	26
Targeting type I collagen for cancer treatment	26
The impact of the COVID‐19 pandemic on the short‐term survival of patients with cancer in Northern Portugal	26
Emerging role of oncogenic long noncoding RNA as cancer biomarkers	26
Research on esophageal cancer: With personal perspectives from studies in China and Kenya	26
Performance of HPV E6/E7 mRNA assay as primary screening test: Results from the NTCC2 trial	25
Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis	25
Pegilodecakin as monotherapy or in combination with anti‐PD‐1 or tyrosine kinase inhibitor in heavily pretreated patients with advanced renal cell carcinoma: Final results of cohorts A	25
Circulating tryptophan metabolites and risk of colon cancer: Results from case‐control and prospective cohort studies	25
PARP mediated DNA damage response, genomic stability and immune responses	25
Selenium and cancer risk: Wide‐angled Mendelian randomization analysis	25
Low‐dose pembrolizumab in the treatment of advanced non‐small cell lung cancer	25
Adolescent use of hair dyes, straighteners and perms in relation to breast cancer risk	24
Classification of high‐grade cervical intraepithelial neoplasia by p16ink4a, Ki‐67, HPV E4 and FAM19A4/miR124‐2 methylation status demonstrates consi	24
Targeting CTLA‐4 in cancer: Is it the ideal companion for PD‐1 blockade immunotherapy combinations?	24
Panel gene profiling of small bowel adenocarcinoma: Results from theNADEGEprospective cohort	24
The interplay of oncogenic signaling, oxidative stress and ferroptosis in cancer	24
Chronic acidosis rewires cancer cell metabolism through PPARα signaling	24
Single‐cell RNA‐seq dissecting heterogeneity of tumor cells and comprehensive dynamics in tumor microenvironment during lymph nodes metastasis in gastric cancer	24
Fake data, paper mills, and their authors: The International Journal of Cancer reacts to this threat to scientific integrity	24
The evidence base of US Food and Drug Administration approvals of novel cancer therapies from 2000 to 2020	24
Exploiting epigenetic dependencies in ovarian cancer therapy	24
Weight change in middle adulthood and risk of cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort	24
Prospective study of oral microbiome and gastric cancer risk among Asian, African American and European American populations	23
Risk of cardiovascular disease following gonadotropin‐releasing hormone agonists vs antagonists in prostate cancer: Real‐world evidence from five databases	23
Age‐specific burden of cervical cancer associated with HIV: A global analysis with a focus on sub‐Saharan Africa	23
Cancer‐associated fibroblasts in nonsmall cell lung cancer: From molecular mechanisms to clinical implications	23
Postdiagnosis recreational physical activity and breast cancer prognosis: Global Cancer Update Programme (CUP Global) systematic literature review and meta‐analysis	23
Thyroid cancer and its associated factors: A population‐based case‐control study	23
Associations of vitamin D status with colorectal cancer risk and survival	23
Cancer and the risk of coronavirus disease 2019 diagnosis, hospitalisation and death: A population‐based multistate cohort study including 4 618 377 adults in Catalonia, Spain	23
Genome‐wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility	23
Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia	23
First‐line nivolumab plus chemotherapy vs chemotherapy in patients with advanced gastric, gastroesophageal junction and esophageal adenocarcinoma: CheckMate 649 Chinese subgroup analysis	23
Pan‐cancer analysis of prognostic metastatic phenotypes	23
Global patterns of non‐Hodgkin lymphoma in 2020	23
Cumulative COVID‐19 incidence, mortality and prognosis in cancer survivors: A population‐based study in Reggio Emilia, Northern Italy	23
Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma	22
Colorectal cancer survival in sub‐Saharan Africa by age, stage at diagnosis and Human Development Index: A population‐based registry study	22
CD33‐directed immunotherapy with third‐generation chimeric antigen receptor T cells and gemtuzumab ozogamicin in intact and CD33‐edited acute myeloid leukemia and hematopoietic s	22
Risk of breast cancer and prediagnostic urinary excretion of bisphenol A, triclosan and parabens: The Multiethnic Cohort Study	22
C‐reactive protein trajectories and the risk of all cancer types: A prospective cohort study	22
Occupational exposure to nickel and hexavalent chromium and the risk of lung cancer in a pooled analysis of case‐control studies (SYNERGY)	22
Statin use and incidence and mortality of breast and gynecology cancer: A cohort study using the National Health Insurance claims database	22
The association of prediagnostic circulating levels of cardiometabolic markers, testosterone and sex hormone‐binding globulin with risk of breast cancer among normal weight postmenopausal women in the	22
Exploring the impact of gut microbiota and diet on breast cancer risk and progression	22
Dynamic microbiome and metabolome analyses reveal the interaction between gut microbiota andanti‐PD‐1 based immunotherapy in hepatocellular carcinoma	21
Risk factors for immune‐related adverse events from anti‐PD‐1 or anti‐PD‐L1 treatment in an Asian cohort of nonsmall cell lung cancer patients	21
Role of cardiac MRI in the diagnosis of immune checkpoint inhibitor‐associated myocarditis	21
Untargeted plasma metabolomics for risk prediction of hepatocellular carcinoma: A prospective study in two Chinese cohorts	21
Trends in the incidence of cancer in Kampala, Uganda, 1991 to 2015	21
Postdiagnosis dietary factors, supplement use and breast cancer prognosis: Global Cancer Update Programme (CUP Global) systematic literature review and meta‐analysis	21
Combination of Olaparib with radiotherapy for triple‐negative breast cancers: One‐year toxicity report of the RADIOPARP Phase I trial	21
Deep learning‐assisted magnetic resonance imaging prediction of tumor response to chemotherapy in patients with colorectal liver metastases	21
Comprehensive clinicopathologic study of alpha fetoprotein‐expression in a large cohort of patients with hepatocellular carcinoma	21
Noninvasive prognostic biomarker potential of quantifying the propeptides of Type XI collagen alpha‐1 chain (PRO‐C11) in patients with pancreatic ductal adenocarcinoma	21
Clinical performance of methylation as a biomarker for cervical carcinoma in situ and cancer diagnosis: A worldwide study	21
The survival of esophageal cancer by subtype in China with comparison to the United States	21
Toxoplasma gondii infection and the risk of adult glioma in two prospective studies	21
A phase 1 trial of NY‐ESO‐1‐specific TCR‐engineered T‐cell therapy combined with a lymph node‐targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue	21
DNA methylation age as a biomarker for cancer	21
Comparison of liver cancer incidence and survival by subtypes across seven high‐income countries	21
Contemporary management of breast cancer in Nigeria: Insights from an institutional database	20
Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of	20
Serum levels of soluble B and T lymphocyte attenuator predict overall survival in patients undergoing immune checkpoint inhibitor therapy for solid malignancies	20

The oxidized‐LDL/LOX‐1 axis in tumor endothelial cells enhances metastasis by recruiting neutrophils and cancer cells	20
Filgrastim associations with CAR T‐cell therapy	20
Diverging incidence trends of oral tongue cancer compared to other head and neck cancers in young adults in France	20
Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2− metastatic breast cancer patients compared to endocrine therapy alone in the second‐line s	20
Additive value of transarterial embolization to systemic sirolimus treatment in kaposiform hemangioendothelioma	20
Urine biomarkers in cancer detection: A systematic review of preanalytical parameters and applied methods	20
The oral microbiome and breast cancer and nonmalignant breast disease, and its relationship with the fecal microbiome in the Ghana Breast Health Study	20
Tumor promoting capacity of polymorphonuclear myeloid‐derived suppressor cells and their neutralization	20
Transcription factor AP‐2beta in development, differentiation and tumorigenesis	20
Comparative international incidence of Ewing sarcoma 1988 to 2012	20
Natural history of oral HPV infection: Longitudinal analyses in prospective cohorts from Australia	19
Sialic acids in gynecological cancer development and progression: Impact on diagnosis and treatment	19
The impact of the COVID‐19 pandemic on cancer diagnosis based on pathology notifications: A comparison across the Nordic countries during 2020	19
The causal association between smoking, alcohol consumption and risk of bladder cancer: A univariable and multivariable Mendelian randomization study	19
A disease network‐based deep learning approach for characterizing melanoma	19
Assessing the risk of cervical neoplasia in the post‐HPV vaccination era	19
High prevalence of clonal hematopoiesis‐type genomic abnormalities in cell‐freeDNAin invasive gliomas after treatment	19
Missing and decayed teeth, oral hygiene and dental staining in relation to esophageal cancer risk: ESCCAPE case‐control study in Kilimanjaro, Tanzania	19
Patients with colorectal cancer and brain metastasis: The relevance of extracranial metastatic patterns predicting time intervals to first occurrence of intracranial metastasis and survival	19
Cancer risk in patients with bipolar disorder and unaffected siblings of such patients: A nationwide population‐based study	19
Pro‐tumoral behavior of omental adipocyte‐derived fibroblasts in tumor microenvironment at the metastatic site of ovarian cancer	19
The combined action of monocytic myeloid‐derived suppressor cells and mucosal‐associated invariant T cells promotes the progression of cervical cancer	19
Novel mammogram‐based measures improve breast cancer risk prediction beyond an established mammographic density measure	19
A unique urinary metabolomic signature for the detection of pancreatic ductal adenocarcinoma	18
Efficacy and safety of chronomodulated irinotecan, oxaliplatin, 5‐fluorouracil and leucovorin combination as first‐ or second‐line treatment against metastatic colorectal cancer: Results from the Inte	18
The landscape of genetic aberrations in myxofibrosarcoma	18
DNA methylation biomarkers for noninvasive detection of triple‐negative breast cancer using liquid biopsy	18
Upfront treatment with mTOR inhibitor everolimus in pediatric low‐grade gliomas: A single‐center experience	18
Outcomes on anti‐VEGFR‐2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma	18
Causal association of childhood obesity with cancer risk in adulthood: A Mendelian randomization study	18
Oncogenic potential of human pluripotent stem cell‐derived lung organoids with HER2 overexpression	18
Abrogating GPT2 in triple‐negative breast cancer inhibits tumor growth and promotes autophagy	18
Occupational insecticide exposure and risk of non‐Hodgkin lymphoma: A pooled case‐control study from the InterLymph Consortium	18
Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors	18
DNA methylation markers for cancer risk prediction of vulvar intraepithelial neoplasia	18
Survival outcomes of patients with nonsmall cell lung cancer concomitantly receiving proton pump inhibitors and immune checkpoint inhibitors	18
Sarcomatoid hepatocellular carcinoma is distinct from ordinary hepatocellular carcinoma: Clinicopathologic, transcriptomic and immunologic analyses	18
Ultra‐processed food consumption and the risk of pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial	18
Lymphocyte‐activation gene 3 expression associates with poor prognosis and immunoevasive contexture in Epstein‐Barr virus‐positive and MLH1‐defective gastric cancer patients	18
The impact of socioeconomic status on stage at presentation, receipt of diagnostic imaging, receipt of treatment and overall survival in colorectal cancer patients	18
Germline APOBEC3B deletion increases somatic hypermutation in Asian breast cancer that is associated with Her2 subtype, PIK3CA mutations and immune activation	18
Pregnancy outcomes and risk of endometrial cancer: A pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium	18
Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial	18
Impact of the COVID‐19 pandemic on population‐based cancer registry	18
Effects of screening for colorectal cancer: Development, documentation and validation of a multistate Markov model	18
Lifetime incidence risk for gastric cancer in the Helicobacter pylori‐infected and uninfected population in Japan: A Monte Carlo simulation study	17
Association of body composition with risk of overall and site‐specific cancers: A population‐based prospective cohort study	17
Incidence and survival of benign, borderline, and malignant meningioma patients in the United States from 2004 to 2018	17
Morning chronotype and digestive tract cancers: Mendelian randomization study	17
Alternative microexon splicing by RBFOX2 and PTBP1 is associated with metastasis in colorectal cancer	17
Effects of Metformin on the virus/host cell crosstalk in human papillomavirus‐positive cancer cells	17
Contemporary hormonal contraception and cervical cancer in women of reproductive age	17
Statin use and head and neck squamous cell carcinoma outcomes	17
Geospatial barriers to healthcare access for breast cancer diagnosis in sub‐Saharan African settings: The African Breast Cancer—Disparities in Outcomes Cohort Study	17
Cystic fibrosis F508del carriers and cancer risk: Results from the UK Biobank	17
The impact of COVID‐19 on cancer care of outpatients with low socioeconomic status	17
The unfavorable effects of COVID‐19 on Dutch advanced melanoma care	17
“Registries are not only a tool for data collection, they are for action”: Cancer registration and gaps in data for health equity in six population‐based registries in India	17
Extracellular acidity in tumor tissue upregulates programmed cell death ligand 1 expression on tumor cells via proton‐sensing G protein‐coupled receptors	17
Serum core‐type fucosylated prostate‐specific antigen index for the detection of high‐risk prostate cancer	17
A new conditioning regimen with chidamide, cladribine, gemcitabine and busulfan significantly improve the outcome of high‐risk or relapsed/refractory non‐Hodgkin's lymphomas	17
Paid and unpaid productivity losses due to premature mortality from cancer in Europe in 2018	17
High‐fat diet promotes prostate cancer growth through histamine signaling	17
Effect and mechanism of circRNAs in tumor angiogenesis and clinical application	17
Fatty acid‐binding protein 5 limits the generation of Foxp3+ regulatory T cells through regulating plasmacytoid dendritic cell function in the tumor microenvironment	17
Targeting stromal cell Syndecan‐2 reduces breast tumour growth, metastasis and limits immune evasion	17
Impact of two waves of Sars‐Cov2 outbreak on the number, clinical presentation, care trajectories and survival of patients newly referred for a colorectal cancer: A French multicentric coho	17
Patient‐derived tumor organoids predict responses to irinotecan‐based neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer	16
Adverse reactions associated with immune checkpoint inhibitors and bevacizumab: A pharmacovigilance analysis	16
Adherence to a risk‐adapted screening strategy for prostate cancer: First results of the PROBASE trial	16
Crosstalk between tumor acidosis, p53 and extracellular matrix regulates pancreatic cancer aggressiveness	16
Quality diet indexes and risk of hepatocellular carcinoma: Findings from the Singapore Chinese Health Study	16
Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer ri	16
Oncometabolite L‐2‐hydroxyglurate directly induces vasculogenic mimicry through PHLDB2 in renal cell carcinoma	16
ER−/PR+ breast cancer: A distinct entity, which is morphologically and molecularly close to triple‐negative breast cancer	16
Prognostic significance of histopathological response to preoperative chemotherapy in unilateral Wilms' tumor: An analysis of 899 patients treated on the SIOP WT 2001 protocol in the UK‐CCLG and GPOH	16
Cervical lesion assessment using real‐time microendoscopy image analysis in Brazil: The CLARA study	16
Downstream of the HOX genes: Explaining conflicting tumour suppressor and oncogenic functions in cancer	16
Can miRNAs be useful biomarkers in improving prognostic stratification in endometrial cancer patients? An update review	16
Targeting USP13‐mediated drug tolerance increases the efficacy of EGFR inhibition of mutant EGFR in non‐small cell lung cancer	16
Suppression of β‐catenin signaling in colon carcinoma cells by a bacterial protein	16
The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma	16
Small‐area analysis on socioeconomic inequalities in cancer survival for 25 cancer sites in Germany	16
Risk of epithelial ovarian cancer Type I and II after hysterectomy, salpingectomy and tubal ligation—A nationwide case‐control study	16
Human splenic TER cells: A relevant prognostic factor acting via the artemin‐GFRα3‐ERK pathway in pancreatic ductal adenocarcinoma	16
DNA methylation markers as triage test for the early identification of cervical lesions in a Chinese population	16
FOXD1 promotes dedifferentiation and targeted therapy resistance in melanoma by regulating the expression of connective tissue growth factor	16
Nanofitins targeting heat shock protein 110: An innovative immunotherapeutic modality in cancer	16
Immune‐related adverse events predict responses to PD‐1 blockade immunotherapy in hepatocellular carcinoma	15
Urine biomarkers enable pancreatic cancer detection up to 2 years before diagnosis	15
Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy againstMYCN‐amplified neuroblastoma	15
Short tandem repeat profiling for the authentication of cancer stem‐like cells	15
Redesign of a rapid, low‐cost HPV typing assay to support risk‐based cervical screening and management	15
Circulating C‐reactive protein increases lung cancer risk: Results from a prospective cohort of UK Biobank	15
The genomic landscape of young and old lung cancer patients highlights age‐dependent mutation frequencies and clinical actionability in young patients	15